E4/DRSP Single and Multiple Dose PK and Early QT Study
Status:
Completed
Trial end date:
2016-11-21
Target enrollment:
Participant gender:
Summary
This study is conducted to evaluate the effect of single and multiple therapeutic and
supratherapeutic oral doses of E4/DRSP combinations on PK parameters, safety, tolerability
and on cardiac repolarization, as detected by QT interval corrected with Fridericia's formula
(QTcF).